Professor Andrew Holden Joins the VESTECK Scientific Advisory Board

Professor Andrew Holden is currently the Director of Northern Region Interventional Radiology Service and is based at Auckland City Hospital.  As well, he is Professor of Radiology at the University of Auckland and Co-Director of the Auckland Endovascular Service.

Professor Andrew Holden is known worldwide as an educator, clinician and the author of over 100 peer-reviewed articles.  He has been involved in over 75 medical device trials and is a frequent Principal Investigator, personally performing many “first in human” procedures.

“The VESTECK SUTURE-TIGHT catheter appears to be very straightforward, the right technology at the right time,” said Dr. Holden. “Around the world, approximately 80% of all Aortic Abdominal Aneurysm patients needing repairs, receive an endovascular repair (EVAR).  The “SUTURE-TIGHT”TM catheter, fixes the EVAR graft to the aorta. This should significantly reduce the number of patients returning for complex repair procedures and eliminate their associated procedural costs.”

In 2018 Dr. Holden was recognized for his contributions to vascular and endovascular intervention, being awarded an Officer of the New Zealand Order of Merit medal.

We are humbled that Dr. Holden thinks so highly of the VESTECK technology and team to join the Scientific Advisory Board, commented VESTECK CEO Joe Rafferty.  “Professor Holden is respected around the world as a skilled interventionalist and critical thinker. He will absolutely challenge us to bring the finest technology for physicians and patients.”

The VESTECK “SUTURE-TIGHT” catheter secures endovascular aortic repair grafts to the aorta at the time of initial implant or during repair procedures. VESTECK is in preparation for a 100-patient clinical trial.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.